Activity and research directory projects

The directory lists antimicrobial resistance (AMR) activities and research and displays whether they are in progress or completed. Use the filters and search to help refine your query.

9 activities or research projects found
- select to clear
  • 2 June 2020
    Communicable Diseases Intelligence (CDI) is a peer-reviewed scientific journal published by the Office of Health Protection, Department of Health. The journal aims to disseminate information on the epidemiology, surveillance, prevention and control of communicable diseases of relevance to Australia.
    Office of Health Protection, Australian Government Department of Health
  • 1 July 2019
    This project aims to employ novel approaches to discover new-generation polymyxin antibiotics targeting the deadly Gram-negative ‘superbugs’. Novel lead molecules have been licensed to Qpex Biopharma (US) for IND-enabling evaluations with a Phase-I study aimed at 2020.
    Monash University and I (Jian Li, Professor, PhD) am the principal investigator. My project is currently funded by the American National Institutes of Health (NIH). More information at https://www.monash.edu/discovery-institute/news-and-events/news/2019-articles/us-biopharmaceutical-company-licenses-monash-university-superbug-drug-discovery
  • 7 August 2018
    This PhD research project is aimed at investigating alternative regulatory and funding models for antimicrobial drugs. The current economic model (where sales volumes and price determine the return on investment for a drug) does not foster appropriate antimicrobial use. Financial risks associated with AMR has resulted in a decline in the marketing of new drugs & insecurity of supply of current antimicrobials. This project is focused on the Australian market within a global context.
    University of Adelaide
  • 5 July 2018
    WARRA, the Wollongong Antimicrobial Resistance Research Alliance, has developed a workshop series initiative with the aim of engaging pharmacists in the Illawarra Shoalhaven region. The workshop series will provide a continuing professional development (CPD) accredited platform for pharmacists to engage with researchers regarding antibiotic use and antimicrobial resistance.
    University of Wollongong
  • 5 July 2018
    With regional, rural and metropolitan areas and a well-defined coastal strip with a relatively stable population base, the Illawarra Shoalhaven region provides an ideal population to position itself as the ‘Framingham’ of antimicrobial resistance. This large scale project specifically aims to build a longitudinal study across the Illawarra Shoalhaven region to determine all of the factors that are drivers of antimicrobial resistance and to provide a platform for test interventions.
    University of Wollongong, Illawarra Shoalhaven Local Health District
  • 5 July 2018
    WARRA was established as an initiative out of the University of Wollongong, NSW. It aims to generate evidence on antibiotic use and drivers of antimicrobial resistance, to inform future interventions targeting the Illawarra Shoalhaven region. WARRA is comprised of researchers and clinicians specialising in molecular life science, infectious diseases, psychology, nursing, pharmacy, microbiology, pathology and research/project management.
    University of Wollongong, Illawarra Shoalhaven Local Health District
  • 24 April 2018
    The National Centre for Antimicrobial Stewardship (NCAS) is a health services research program that aims to generate evidence on antimicrobial use and stewardship, influence national policy to promote judicious use of antimicrobials across human and animal health, and improve knowledge and build workforce capacity among all stakeholders. NCAS’ research streams include: tertiary hospitals, rural and regional hospitals, aged care homes, general practice, and veterinary and agricultural medicine.
    National Centre for Antimicrobial Stewardship; University of Melbourne; Royal Melbourne Hospital; Peter Doherty Institute for Infection and Immunity; Monash University.
  • 24 April 2018
    The Guidance Group is an initiative of the Royal Melbourne Hospital that develops and provides clinical stewardship solutions: electronic tools that assist hospitals and other clinical facilities to improve their prescribing and undertake auditing. The Group is dedicated to improving the quality and safety of patient care, and its tools are built by clinicians for clinicians, to fit the clinical workflow in diverse healthcare settings.
    Guidance Group at the Royal Melbourne Hospital.
  • 24 April 2018
    The National Antimicrobial Prescribing Survey (NAPS) is a standardised auditing tool that is designed to assist healthcare facilities to assess the quantity and quality of local antimicrobial prescribing. There are several modules available: the Hospital NAPS, Surgical NAPS and Quality Improvement NAPS for hospitals; and the Aged Care NAPS for residential age care homes. A General Practice NAPS and Hospital-in-the-Home NAPS have been piloted, and a Veterinary NAPS is in development.
    National Centre for Antimicrobial Stewardship; Guidance Group at the Royal Melbourne Hospital; VICNISS Coordinating Centre at the Royal Melbourne Hospital; Australian Commission on Safety and Quality in Health Care.